Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, noninferiority trial. - Dungan, KM; Povedano, ST; Forst, T (Lancet, 2014)
doi:10.1016/S0140-6736(14)60976-4